We are live on ! Find out more
RMCM

Reynders McVeigh Capital Management Portfolio holdings

AUM $1.98B
1-Year Est. Return 23.37%
This Fund
S&P 500
This Quarter Est. Return
+9.81%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$1.63B
AUM Growth
+$132M
Cap. Flow
+$5.32M
Cap. Flow %
0.33%
Top 10 Hldgs %
35.83%
Holding
242
New
13
Increased
68
Reduced
122
Closed
10

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$5.4M
2
TMUS icon
T-Mobile US
TMUS
+$4.18M
3
STKL
SunOpta
STKL
+$3.19M
4
UL icon
Unilever
UL
+$2.34M
5
OTLY
Oatly Group
OTLY
+$2.08M

Top Sells

Rank Stock Value
1
TDOC icon
Teladoc Health
TDOC
+$4.11M
2
NVS icon
Novartis
NVS
+$2.88M
3
XLNX
Xilinx Inc
XLNX
+$1.7M
4
VAR
Varian Medical Systems, Inc.
VAR
+$1.65M
5
FISV
Fiserv Inc
FISV
+$1.5M

Sector Composition

Rank Sector Weight
1 Healthcare 25.91%
2 Technology 19.96%
3 Industrials 13.27%
4 Communication Services 11.51%
5 Consumer Discretionary 10.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDT icon
26
Medtronic
MDT
$116B
$21.4M 1.31%
172,119
+42,982
+33% +$5.4M
BDX icon
27
Becton Dickinson
BDX
$49.4B
$21.4M 1.31%
90,039
+3,816
+4% +$915K
TDOC icon
28
Teladoc Health
TDOC
$1.24B
$21.3M 1.3%
128,032
-25,386
-17% -$4.11M
JNJ icon
29
Johnson & Johnson
JNJ
$626B
$19.6M 1.2%
119,114
-1,853
-2% -$307K
CVS icon
30
CVS Health
CVS
$120B
$19.5M 1.19%
233,245
-3,845
-2% -$315K
WM icon
31
Waste Management
WM
$90.7B
$19M 1.17%
135,754
+3,436
+3% +$475K
NVO
32
Novo Nordisk
NVO
$207B
$18.5M 1.13%
440,642
+37,330
+9% +$1.45M
PG icon
33
Procter & Gamble
PG
$338B
$16.4M 1.01%
121,665
+730
+0.6% +$98.8K
MKTX icon
34
MarketAxess Holdings
MKTX
$5.72B
$16.1M 0.98%
34,634
-68
-0.2% -$32.4K
VEEV icon
35
Veeva Systems
VEEV
$38.4B
$15.8M 0.97%
50,661
-447
-0.9% -$125K
SBUX icon
36
Starbucks
SBUX
$122B
$15.4M 0.94%
137,568
+6,072
+5% +$686K
SYY icon
37
Sysco
SYY
$40.3B
$15.3M 0.94%
197,323
+3,745
+2% +$302K
XLNX
38
DELISTED
Xilinx Inc
XLNX
$14.8M 0.91%
102,525
-13,352
-12% -$1.7M
APH icon
39
Amphenol
APH
$206B
$13.2M 0.81%
387,070
+11,700
+3% +$395K
HD icon
40
Home Depot
HD
$353B
$12.9M 0.79%
40,513
-219
-0.5% -$69.7K
BXP icon
41
Boston Properties
BXP
$10.8B
$12M 0.74%
104,698
+16,451
+19% +$1.85M
NVS icon
42
Novartis
NVS
$294B
$11.9M 0.73%
129,981
-32,366
-20% -$2.88M
TJX icon
43
TJX Companies
TJX
$172B
$10.8M 0.66%
160,487
-1,466
-0.9% -$99.9K
BEAM icon
44
Beam Therapeutics
BEAM
$2.77B
$9.15M 0.56%
71,105
+3,653
+5% +$291K
FISV
45
Fiserv Inc
FISV
$28B
$6.9M 0.42%
64,593
-12,941
-17% -$1.5M
TILE icon
46
Interface
TILE
$2.24B
$6.33M 0.39%
413,815
+94,620
+30% +$1.36M
TMO icon
47
Thermo Fisher Scientific
TMO
$224B
$6.32M 0.39%
12,527
-297
-2% -$140K
ABBV icon
48
AbbVie
ABBV
$442B
$5.4M 0.33%
47,974
-1,219
-2% -$137K
STKL
49
DELISTED
SunOpta
STKL
$5.34M 0.33%
435,989
+244,515
+128% +$3.19M
ENPH icon
50
Enphase Energy
ENPH
$5.59B
$5.14M 0.32%
28,007
+3,442
+14% +$505K
1
2
3 4 5

Similar funds

SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
MYAM
Meiji Yasuda Asset Management Tokyo, Japan $2B AUM 22.52% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
C
Consulta London, United Kingdom $2.01B AUM 16.82% 1-Year Est. Return

Reynders McVeigh Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Reynders McVeigh Capital Management held 242 positions worth $1.63B, up 8.8% from $1.5B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Reynders McVeigh Capital Management's Q2 2021 filing shows 13 new, 68 increased, 122 reduced and 10 closed positions. Its largest new stake was Oatly Group: 4,177 shares worth $2.04M. The largest sale was Teladoc Health, an estimated $4.11M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 26% a quarter earlier, followed by Technology and Industrials.

  • Reynders McVeigh Capital Management's largest Q2 2021 buy was Oatly Group: 4,177 shares worth $2.04M.
  • Reynders McVeigh Capital Management added most to Medtronic in Q2 2021, an estimated $5.4M increase.
  • Reynders McVeigh Capital Management's biggest Q2 2021 reduction was Teladoc Health, cutting an estimated $4.11M.
  • Reynders McVeigh Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.65M.
  • Reynders McVeigh Capital Management's ten largest holdings make up 36% of its $1.63B portfolio in Q2 2021.
  • Reynders McVeigh Capital Management opened 13 new positions and closed 10 in Q2 2021.
  • Reynders McVeigh Capital Management's portfolio value rose 8.8% quarter-over-quarter to $1.63B.

Based on Reynders McVeigh Capital Management's 13F filing for Q2 2021, filed 12 Aug 2021.